Featured Videos #1

Treatments to improve cardiorenal outcomes in CKD. ‘Known knowns and known unknowns’

10 October 2024

Boehringer Ingelheim and Lilly Alliance has provided funding towards this educational programme. The Alliance has had no editorial input or influence on the agenda, collateral content of this meeting including the selection of speakers.

Cardiorenal changes in later life

10 October 2024

This webinar has been sponsored by A Menarini Pharmaceuticals Ireland and A. Menarini Farmaceutica Internazionale SRL who have had no input into the topics discussed or selection of speakers.

Pitfalls in heart failure – Digoxin toxicity in the elderly

9 September 2024

Watch this informative video short, featuring Dr Paul Andrews as he describes some of the pitfalls of digoxin use within the elderly population and explores ways to minimise the risks and correctly identify when to take action to treat potentially life threatening scenarios.

Masterclass: Treating dyslipidaemia – special populations

8 August 2024

In this masterclass, Alison Pottle and Jai Cegla provide discuss screening for familial hypercholesterolaemia (FH), treatment advances in dyslipidaemia, the role of lipid apheresis in specific populations and the importance of patient education.

Key highlights from Heart Failure 2024 – Annual congress of the Heart Failure Association of the ESC

8 August 2024

Professor Paul Kalra summarises key findings presented at the 2024 Heart Failure Association ESC meeting in Lisbon. He discusses the new data on hypertrophic cardiomyopathy, heart failure with reduced ejection fraction, and challenges in diagnosis and treatment optimisation. He also explores the early benefits of sodium-glucose co-transporter 2 inhibitors and evidence-based treatments for heart failure with preserved ejection fraction.

Harmonising the guidelines: making sense of lipid treatment advice

23 July 2024

Watch Terry McCormack and Rani Khatib discuss the updates to lipid management guidelines to reduce the risk of cardiovascular disease and implications for clinical practice. They will provide an overview of which patients should be treated, outline the current lipid-lowering targets and introduce the range of suitable treatments.